News
India to Make these Changes to Encourage Export of Medical Devices
The South East Asia Medical Device markets including Korea, Indonesia, Thailand, Malaysia, India, Philippines, Singapore, Malaysia and Vietnam have been growing at a higher rate than the developed medical device markets of the Western world. These countries have shown high rate of imports in medical devices, larger expenditure by the private and
Register with Pharma Data Bank or Face Penal Action
Drugs in India are regulated by the CDSCO and the NPPA. The CDSCO monitors clinical trials, regulatory approvals, import / export and quality control for pharmaceutical products, whilst the NPAA is involved in the price regulation for pharmaceuticals in the Indian market. The National Pharmaceutical Pricing Authority (NPPA) has set
Ethics Committee Accreditation is Essential Now in this Country
The Central Drug Standards Control Organisation regulates the clinical trials for drugs and medical devices in India. Demonstration of safety and efficacy of the drug product for use in humans is essential before the drug product can be approved for import or manufacturing and marketing in the country (Read About
India’s first dedicated Medical Device Park to come up in Andhra Pradesh
The 200 acre exclusive park will spur domestic production of medical devices, help reduce import dependency in this sector while creating employment and growth in the state. India primarily depends on imports for the medical device sector. Over 85% of medical devices are imported into the country causing a high
India’s CDSCO Offers Four New Updates to Promote Clinical Research
The Central Drugs Standard Control Organization (CDSCO) is the primary body which regulates medical devices, drugs, cosmetics, in vitro diagnostics in the Indian subcontinent. This body is also responsible for the monitoring and approval of clinical trials and research in the country. Early this year, several amendments were made the
Centre sanctions US$ 150 bn to CDSCO for integrating e-governance across states with national portal
The Central Drugs Standard Control Organization (CDSCO) is currently undergoing several transformations to upgrade the regulatory systems for medical devices, drugs, in vitro diagnostics and cosmetic approval processes. The registration process is done with New Delhi as the Head Quarters. By linking the different offices with e-governance the CDSCO would improve
India To Double The Size Of Medical Tourism Market By 2020
The size of the medical tourism market in India is expected to touch US $8 billion by 2020 from its current worth of US $3 billion. This is due to the costs for healthcare in the developed countries is getting higher. For around 80% of the medical tourists cost is
India Moves Forward in Ease of Doing Business
The latest World Bank report states that India had move forward 12 places in ease of doing business list is a remarkable growth considering the size of the economy. Last year India ranked 142 and now it has moved to 130 out of the 189 countries. World Bank’s Chief Economist
Drug Regulator of Japan Opens Office in India
The Drug regulator of Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) is set to open their office in India due to concerns over aging population and healthcare costs of branded drugs. This move of Japan’s drug regulator will help out the Indian generic drug manufacturers who are looking to
Competitive Practices in Pharma Sector – A Study
The Competition Commission of India (CCI) is planning to execute a study on pharmaceutical and healthcare sectors in the NCR region due to the concerns over the speculations of unfair ways of competition. The study would cover pharma companies, its associations, public and private hospitals, insurance companies, doctors and their